0001140361-21-011991.txt : 20210407
0001140361-21-011991.hdr.sgml : 20210407
20210407161522
ACCESSION NUMBER: 0001140361-21-011991
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210405
FILED AS OF DATE: 20210407
DATE AS OF CHANGE: 20210407
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Georgantas Robert William III
CENTRAL INDEX KEY: 0001827728
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39659
FILM NUMBER: 21812280
MAIL ADDRESS:
STREET 1: 2970 WILDERNESS PLACE
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIODESIX INC
CENTRAL INDEX KEY: 0001439725
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 203986492
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2970 WILDERNESS PLACE
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 303-417-0500
MAIL ADDRESS:
STREET 1: 2970 WILDERNESS PLACE
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
form4.xml
X0306
4
2021-04-05
0001439725
BIODESIX INC
BDSX
0001827728
Georgantas Robert William III
2970 WILDERNESS PLACE
SUITE 100
BOULDER
CO
80301
true
true
SVP, Rsrch & Trans'l Science
Common Stock
2021-04-05
4
M
0
10219
0.77
A
10774
D
Common Stock
100
I
By UGMA Account
Stock Option (Right to buy)
0.77
2021-04-05
4
M
0
10219
0
D
2030-04-14
Common Stock
10219
19262
D
This option vests 20% on January 1, 2021, and the remaining 80% in 48 successive, equal monthly installments measured from January 1, 2021.
This Form 4 corrects the exercise price previously reported as $0.78 on the Form 3 filed on October 27, 2020.
/s/ Robin H. Cowie as Attorney-in-Fact for Robert Georgantas III
2021-04-07